MORN vs SRPT · P/E 17, rev $1.31B vs rev $1.13B
Morningstar Inc (MORN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Morningstar Inc (MORN) is a financial data & stock exchanges company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MORN revenue for 2026-06-30 was $1.31B. Net income was $214.9M. MORN currently screens at market cap $6.25B and trailing P/E 16.8.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
MORN currently screens at market cap $6.25B and trailing P/E 16.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MORN and SRPT stock pages for the full models.
Not investment advice.